CVR 31611083Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)HellerupFounded 1 Jul 2008
1 registered in CVR.
P-number 1014602468Tingskiftevej 6, 2900 Hellerup
Source: the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen. Annual reports via XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Connect Dandex to Claude, ChatGPT or Cursor to compare years, check credit and map the people around a company.
Employees
1
Annual report 2025, average
Gross profit
-37,6K
DKK, annual report 2025
-46,3K on 2024
Result
-67,1K
DKK, annual report 2025
Equity
-632,8K
DKK, annual report 2025
KLAUS TRIER HOLDING ApSCVR 31283388, 100% of capital and votes, since 1 Jul 2008
Klaus Triersince 1 Jul 2008
Equity was negative at 31 Dec 2025: -632,8K DKK. Dandex estimate, computed 20 Oct 2026.
CVR 31283388100% of capital and votessince 1 Jul 2008
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 1831090266,7% to under 90% of capital and votes1 Jul 2008 to 10 Sep 2026
Ultimate controller
Holds 100% of capital and votes in KLAUS TRIER HOLDING ApS, since 5 Mar 2008
Holding company
CVR 31283388Private limited company (ApS)
Holds 100% of capital and votes in TRIER PHARM ApS, since 1 Jul 2008
This company
TRIER PHARM ApS
CVR 31611083
CVR records founders at incorporation. It does not record whether they are alive or still involved.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | 32 | 61 | -86 | 9 | -38 |
| Result for the year | +9 | +36 | -116 | -19 | -67 |
| Equity | -467 | -431 | -547 | -566 | -633 |
| Total assets | 508 | 259 | 278 | 170 | 201 |
| Employees (average) | Not reported | Not reported | Not reported | 1 | 1 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | n.m.note 1 | 91,6% | -241,5% | n.m.note 1 | -535% |
| Employee growth (vækst i antal ansatte) | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 | 0% | 0% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -154note 3 | -216note 3 | -21note 3 | -20note 3 | -2note 3 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 747note 3 | 410note 3 | 759note 3 | 688note 3 | 796note 3 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 3 Jul 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 26 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 27 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 4 May 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 28 Jun 2022
TRIER PHARM ApS has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 8 Jan 2027.
